Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Thomas Quemeneur"'
Autor:
Achille Aouba, Julien Rossignol, Matthieu Mahévas, Damien Roos-Weil, Pierre Hirsch, Anna Sevoyan, Yervand Hakobyan, Sébastien Miranda, Louis Terriou, Julie Graveleau, Gwenola Maigne, Matthieu Groh, Thomas Quemeneur, Florent Malard, Marie Sebert, Sophie Georgin-Lavialle, Artem Oganesyan, Arsène Mekinian, Nabil Belfeki, Pierre Fenaux, Matthieu Decamp, Laurent Sailler, Louis Drevon, M. Delplanque, Jerome Razanamahery
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, 2021, 10 (23), pp.5586. ⟨10.3390/jcm10235586⟩
Journal of Clinical Medicine, MDPI, 2021, 10 (23), pp.5586. ⟨10.3390/jcm10235586⟩
Journal of Clinical Medicine; Volume 10; Issue 23; Pages: 5586
Journal of Clinical Medicine, Vol 10, Iss 5586, p 5586 (2021)
Journal of Clinical Medicine, 2021, 10 (23), pp.5586. ⟨10.3390/jcm10235586⟩
Journal of Clinical Medicine, MDPI, 2021, 10 (23), pp.5586. ⟨10.3390/jcm10235586⟩
Journal of Clinical Medicine; Volume 10; Issue 23; Pages: 5586
Journal of Clinical Medicine, Vol 10, Iss 5586, p 5586 (2021)
International audience; Background: Patients with solid cancers and hematopoietic malignancy can experience systemic symptoms compatible with adult-onset Still’s disease (AOSD). The newly described VEXAS, associated with somatic UBA1 mutations, exh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e2e510246a9ef755fc33b3b1a67b40
https://hal.sorbonne-universite.fr/hal-03511806/document
https://hal.sorbonne-universite.fr/hal-03511806/document
Autor:
Antoine Lafarge, Mohamed Hamidou, Matthieu Groh, Pacal Cohen, Alexandre Karras, Christian Pagnoux, Camillo Ribi, Xavier Puéchal, Benjamin Terrier, Luc Mouthon, Thomas Quemeneur, Loïc Guillevin, Maxime Samson, Adrien Joseph
Publikováno v:
Annals of the Rheumatic Diseases. 79:431-433
Reduction in cyclophosphamide cumulative dose and introduction of newer immunosuppressive drugs may reduce the malignant burden of systemic necrotising vasculitis (SNV).1 2 This study aimed to describe malignancies recorded in five randomised control
Autor:
Dimitri Titeca-Beauport, Vincent Audard, Laurent Juillard, Marie-Noëlle Peraldi, Jean-François Subra, Eric Thervet, Jean-Michel Halimi, Thierry Lobbedez, Gabriel Choukroun, Mathilde Tamain, Marc Hazzan, Alexandre Ganea, Maité Daroux, Thomas Quemeneur, Dominique Guerrot, Pauline Caillard, Marie Essig, François Vrtovsnik, Jean-Michel Rebibou, Cécile Vigneau, R. Makdassi, Marion Rabant, Morgane Heitz, Vincent Vuiblet, Alexandre Hertig, Adnane Lamrani
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, 2020, 9 (3), pp.698. ⟨10.3390/jcm9030698⟩
Journal of Clinical Medicine, MDPI, 2020, 9 (3), pp.698. ⟨10.3390/jcm9030698⟩
Journal of Clinical Medicine, Vol 9, Iss 3, p 698 (2020)
Volume 9
Issue 3
Journal of Clinical Medicine, 2020, 9 (3), pp.698. ⟨10.3390/jcm9030698⟩
Journal of Clinical Medicine, MDPI, 2020, 9 (3), pp.698. ⟨10.3390/jcm9030698⟩
Journal of Clinical Medicine, Vol 9, Iss 3, p 698 (2020)
Volume 9
Issue 3
In patients presenting with anti-glomerular basement membrane (GBM) disease with advanced isolated kidney involvement, the benefit of intensive therapy remains controversial due to adverse events, particularly infection. We aim to describe the burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be29c3daa88cebea92dd6012c54246f7
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02796989/document
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02796989/document
Autor:
Camille Francès, Christophe Deligny, Bernard Imbert, Emmanuel Chatelus, L. Boukari, Noémie Le Gouellec, Claire Cazalets, Patricia Senet, Arsène Mekinian, Thierry Martin, Patrick Jego, Christian Agard, Thomas Quemeneur, David Launay, Pierre-Yves Hatron, Alexis Mathian, Sébastien Rivière, Alain Le Quellec, Alban Deroux, Grégory Pugnet, Alain Lescoat, Thomas Sené, Silvia Speca, Olivier Fain, Sébastien Sanges, Eric Hachulla, Sylvain Dubucquoi
Publikováno v:
Autoimmunity Reviews
Autoimmunity Reviews, 2017, 16 (4), pp.377-384. ⟨10.1016/j.autrev.2017.02.008⟩
Autoimmunity Reviews, Elsevier, 2017, 16 (4), pp.377-384. ⟨10.1016/j.autrev.2017.02.008⟩
Autoimmunity Reviews, 2017, 16 (4), pp.377-384. ⟨10.1016/j.autrev.2017.02.008⟩
Autoimmunity Reviews, Elsevier, 2017, 16 (4), pp.377-384. ⟨10.1016/j.autrev.2017.02.008⟩
International audience; BACKGROUND:As intravenous immunoglobulins (IVIG) exhibit immunomodulatory and antifibrotic properties, they may be a relevant treatment for systemic sclerosis (SSc). The objectives of this work were thus to report on the effic
Autor:
Maxime Samson, Yoann Crabol, Bernard Bonnotte, Olivier Aumaître, Noémie Jourde-Chiche, Benjamin Terrier, Mikael Ebbo, Cécile-Audrey Durel, Loïc Guillevin, Alexandre Belot, Xavier Puéchal, Jean-Christophe Lega, Frederic Vandergheynst, Pierre Charles, Thomas Quemeneur, Grégory Pugnet, Camillo Ribi
Publikováno v:
La Presse Médicale. 49:104031
Treatment of vasculitides associated with anti-neutrophil cytoplasm antibodies (ANCA) (AAVs) has evolved dramatically in recent years, particularly since the demonstration of rituximab efficacy as remission induction and maintenance therapy for granu
Autor:
Alain Le Quellec, Jean-François Viallard, Noémie Jourde Chiche, Alexis Régent, Arsène Mekinian, Benjamin Terrier, Pascal Cohen, Marc Ruivard, François Maurier, Luc Mouthon, Yann Nguyen, Jacques Pourrat, Thomas Quemeneur, Xavier Puéchal, Mohamed Hamidou, François Lifermann, Pascal Godmer, Eric Hachulla, Alexandre Karras, Loïc Guillevin, Chahéra Khouatra, Christian Pagnoux
Publikováno v:
Journal of Autoimmunity. 112:102467
Objective To describe characteristics and long-term outcomes of patients with microscopic polyangiitis (MPA), an antineutrophil cytoplasm antibody (ANCA)-associated small-vessel necrotizing vasculitis. Methods MPA patients from the French Vasculitis
Publikováno v:
Seminars in Arthritis and Rheumatism. 46:e3-e5
Autor:
Robin Dhote, Christophe Deligny, Charlotte Durtette, Edouard Pertuiset, Christian Lavigne, Anne Grasland, Thomas Quemeneur, Eric Hachulla, Thomas Papo, Pascal Sève, Matthieu Resche-Rigon, Pierre-Yves Hatron, Thierry Zenone, Marc Lambert, Arsène Mekinian, Thomas Le Gallou, Benoit De Wazieres, Mohamed Hamidou, Guillaume Gondran, Cédric Landron, Bertrand Lioger, Jacques Pouchot, Jean Emmanuel Kahn, Snfmi, Olivier Fain
Publikováno v:
Autoimmunity Reviews
Autoimmunity Reviews, Elsevier, 2017, 16 (12), pp.1219-1223. ⟨10.1016/j.autrev.2017.10.005⟩
Autoimmunity Reviews, Elsevier, 2017, 16 (12), pp.1219-1223. ⟨10.1016/j.autrev.2017.10.005⟩
Background Cogan syndrome is mainly treated with steroids. We aimed to determine the place of DMARDs and biologic-targeted treatments. Patients and methods We conducted a French nationwide retrospective study of patients with Cogan syndrome (n = 40)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d70331cd14a55f4f5e350184663547df
https://hal.archives-ouvertes.fr/hal-01891845
https://hal.archives-ouvertes.fr/hal-01891845
Autor:
Olivier Aumaître, Olivier Lidove, Chahéra Khouatra, Olivier Decaux, Pascal Cohen, P. Gobert, Claire Blanchard-Delaunay, Philippe Ravaud, Pascal Godmer, Xavier Puéchal, Mohamed Hamidou, Hélène Desmurs-Clavel, Pierre-Louis Carron, Elodie Perrodeau, Marize Ducret, Bernard Bonnotte, Thomas Quemeneur, Christian Pagnoux, François Maurier, Benjamin Terrier, Eric Daugas, Luc Mouthon, Nicolas Limal, Loïc Guillevin, A. Karras
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
Annals of the Rheumatic Diseases, 2018, 〈10.1136/annrheumdis-2017-212768〉
Annals of the Rheumatic Diseases, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
Annals of the Rheumatic Diseases, 2018, 〈10.1136/annrheumdis-2017-212768〉
Annals of the Rheumatic Diseases, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
International audience; Objective - To compare long-term efficacy of remission-maintenance regimens in patients with newly diagnosed or relapsing antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides. Methods - The 28-month Maintenance
Publikováno v:
La Revue de Médecine Interne. 38:A119-A120
Introduction La periarterite noueuse (PAN) est une vascularite systemique necrosante touchant les arteres de moyen et petit calibre [1] . Des formes limitees a la peau, aux muscles ou aux membres inferieurs ont ete decrites [2] . Le diagnostic repose